As of March 20, 2023, over 13 billion COVID-19 vaccine doses had been administered worldwide, with the United States accounting for almost 672 million of this total. This statistic shows the number of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country.

As of March 20, 2023, around 391 doses of COVID-19 vaccines per 100 people in Cuba had been administered, one of the highest COVID-19 vaccine dose rates of any country worldwide. This statistic shows the rate of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country or territory.

This is a dataset from Our World in Data that delves into the global landscape of COVID-19 vaccinations. Our World in Data is renowned for its comprehensive and reliable datasets, offering in-depth insights into various global issues. This particular dataset is expected to provide up-to-date and detailed information regarding the progress of COVID-19 vaccination campaigns worldwide. It likely includes visualizations and analyses of vaccination trends, covering aspects such as the total number of vaccine doses administered, vaccination coverage across different countries, and potentially, the distribution and types of vaccines utilized. As a valuable resource, this dataset can contribute significantly to a better understanding of the global efforts to combat the COVID-19 pandemic through vaccination initiatives.

Link Dataset: (https://ourworldindata.org/covid-vaccinations#citation)

About this Dataset

The data contains the following information:

Country- this is the country for which the vaccination information is provided; Country ISO Code - ISO code for the country; Date - date for the data entry; for some of the dates we have only the daily vaccinations, for others, only the (cumulative) total; Total number of vaccinations - this is the absolute number of total immunizations in the country; Total number of people vaccinated - a person, depending on the immunization scheme, will receive one or more (typically 2) vaccines; at a certain moment, the number of vaccination might be larger than the number of people; Total number of people fully vaccinated - this is the number of people that received the entire set of immunization according to the immunization scheme (typically 2); at a certain moment in time, there might be a certain number of people that received one vaccine and another number (smaller) of people that received all vaccines in the scheme; Daily vaccinations (raw) - for a certain data entry, the number of vaccination for that date/country; Daily vaccinations - for a certain data entry, the number of vaccination for that date/country; Total vaccinations per hundred - ratio (in percent) between vaccination number and total population up to the date in the country; Total number of people vaccinated per hundred - ratio (in percent) between population immunized and total population up to the date in the country; Total number of people fully vaccinated per hundred - ratio (in percent) between population fully immunized and total population up to the date in the country; Number of vaccinations per day - number of daily vaccination for that day and country; Daily vaccinations per million - ratio (in ppm) between vaccination number and total population for the current date in the country; Vaccines used in the country - total number of vaccines used in the country (up to date); Source name - source of the information (national authority, international organization, local organization etc.); Source website - website of the source of information;

Tasks: Track the progress of COVID-19 vaccination What vaccines are used and in which countries? What country is vaccinated more people? What country is vaccinated a larger percent from its population?

This data is valuble in relation to the health, financial, and engineering sectors.

Category

Health & Medicine

Keywords

Health,Medicine,covid-19,dataset,progress

Row Count

5824

Price

$120.00

As of December 23, 2022, around 80 percent of the population of the United States had been given at least one dose of a COVID-19 vaccination. This statistic shows the percentage of population in select countries and territories worldwide that had received a COVID-19 vaccination as of December 23, 2022.

The number of COVID-19 vaccination doses administered in the World rose to 9976338443 as of Jan 27 2022. This dataset includes a chart with historical data for World Coronavirus Vaccination Total.

Analysis of ‘COVID vaccination vs. mortality ’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/sinakaraji/covid-vaccination-vs-death on 12 November 2021.

--- Dataset description provided by original source is as follows ---

Context

The COVID-19 outbreak has brought the whole planet to its knees.More over 4.5 million people have died since the writing of this notebook, and the only acceptable way out of the disaster is to vaccinate all parts of society. Despite the fact that the benefits of vaccination have been proved to the world many times, anti-vaccine groups are springing up all over the world. This data set was generated to investigate the impact of coronavirus vaccinations on coronavirus mortality.

Content

country	iso_code	date	total_vaccinations	people_vaccinated	people_fully_vaccinated	New_deaths	population	ratio
country name	iso code for each country	date that this data belong	number of all doses of COVID vaccine usage in that country	number of people who got at least one shot of COVID vaccine	number of people who got full vaccine shots	number of daily new deaths	2021 country population	% of vaccinations in that country at that date = people_vaccinated/population * 100

Data Collection

This dataset is a combination of the following three datasets:

1.https://www.kaggle.com/gpreda/covid-world-vaccination-progress

2.https://covid19.who.int/WHO-COVID-19-global-data.csv

3.https://www.kaggle.com/rsrishav/world-population

you can find more detail about this dataset by reading this notebook:

https://www.kaggle.com/sinakaraji/simple-linear-regression-covid-vaccination

Countries in this dataset:

Afghanistan	Albania	Algeria	Andorra	Angola
Anguilla	Antigua and Barbuda	Argentina	Armenia	Aruba
Australia	Austria	Azerbaijan	Bahamas	Bahrain
Bangladesh	Barbados	Belarus	Belgium	Belize
Benin	Bermuda	Bhutan	Bolivia (Plurinational State of)	Brazil
Bosnia and Herzegovina	Botswana	Brunei Darussalam	Bulgaria	Burkina Faso
Cambodia	Cameroon	Canada	Cabo Verde	Cayman Islands
Central African Republic	Chad	Chile	China	Colombia
Comoros	Cook Islands	Costa Rica	Croatia	Cuba
Curaçao	Cyprus	Denmark	Djibouti	Dominica
Dominican Republic	Ecuador	Egypt	El Salvador	Equatorial Guinea
Estonia	Ethiopia	Falkland Islands (Malvinas)	Fiji	Finland
France	French Polynesia	Gabon	Gambia	Georgia
Germany	Ghana	Gibraltar	Greece	Greenland
Grenada	Guatemala	Guinea	Guinea-Bissau	Guyana
Haiti	Honduras	Hungary	Iceland	India
Indonesia	Iran (Islamic Republic of)	Iraq	Ireland	Isle of Man
Israel	Italy	Jamaica	Japan	Jordan
Kazakhstan	Kenya	Kiribati	Kuwait	Kyrgyzstan
Lao People's Democratic Republic	Latvia	Lebanon	Lesotho	Liberia
Libya	Liechtenstein	Lithuania	Luxembourg	Madagascar
Malawi	Malaysia	Maldives	Mali	Malta
Mauritania	Mauritius	Mexico	Republic of Moldova	Monaco
Mongolia	Montenegro	Montserrat	Morocco	Mozambique
Myanmar	Namibia	Nauru	Nepal	Netherlands
New Caledonia	New Zealand	Nicaragua	Niger	Nigeria
Niue	North Macedonia	Norway	Oman	Pakistan
occupied Palestinian territory, including east Jerusalem
Panama	Papua New Guinea	Paraguay	Peru	Philippines
Poland	Portugal	Qatar	Romania	Russian Federation
Rwanda	Saint Kitts and Nevis	Saint Lucia
Saint Vincent and the Grenadines	Samoa	San Marino	Sao Tome and Principe	Saudi Arabia
Senegal	Serbia	Seychelles	Sierra Leone	Singapore
Slovakia	Slovenia	Solomon Islands	Somalia	South Africa
Republic of Korea	South Sudan	Spain	Sri Lanka	Sudan
Suriname	Sweden	Switzerland	Syrian Arab Republic	Tajikistan
United Republic of Tanzania	Thailand	Togo	Tonga	Trinidad and Tobago
Tunisia	Turkey	Turkmenistan	Turks and Caicos Islands	Tuvalu
Uganda	Ukraine	United Arab Emirates	The United Kingdom	United States of America
Uruguay	Uzbekistan	Vanuatu	Venezuela (Bolivarian Republic of)	Viet Nam
Wallis and Futuna	Yemen	Zambia	Zimbabwe

--- Original source retains full ownership of the source dataset ---

The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page.

Snapshot img

Covid-19 Vaccination Market 2024-2028

The covid-19 vaccination market size is forecast to increase by USD -32.76 billion, at a CAGR of -37.4% between 2023 and 2028. The market is experiencing significant growth due to the expansion of vaccination programs worldwide. Governments and international organizations are investing heavily in vaccination initiatives to contain the spread of the virus. The rising research and development (R&D) investment in the development of Covid-19 vaccines is another major growth factor. However, the high cost of production of Covid-19 vaccines poses a significant challenge to market growth. Manufacturers are exploring various strategies to reduce production costs while maintaining vaccine efficacy and safety. The market is expected to witness strong growth in the coming years as more effective and affordable vaccines become available. poiuyfrtyh

What will the Covid-19 Vaccination Market Size be During the Forecast Period?

Download Report Sample to Unlock the Covid-19 Vaccination Market Size for the Forecast Period and Other Important Statistics

Market Dynamics

The COVID-19 pandemic has brought about an unprecedented global health crisis, leading to the development of numerous vaccines to mitigate its impact. This content focuses on various aspects of COVID-19 vaccines, including production, distribution, administration, efficacy, safety, and regulations. COVID-19 vaccine production has been a top priority for researchers and pharmaceutical companies worldwide. Several manufacturers have developed vaccines using various technologies such as mRNA, viral vector, and protein subunit, undergoing rigorous testing and clinical trials to ensure safety and efficacy. Once vaccines receive approval from regulatory bodies, they are distributed to healthcare facilities and vaccination centers, requiring careful planning and coordination. Governments and international organizations are working to ensure equitable distribution, prioritizing vulnerable populations and herd immunity. Vaccine administration involves healthcare professionals delivering vaccines through injections, with proper training and safety protocols to minimize adverse reactions. Efficacy refers to the vaccine's ability to prevent infection or reduce the severity of symptoms, with most vaccines showing high efficacy rates, ranging from 60% to 95%. Vaccine safety is monitored closely, and while common side effects include pain and swelling at the injection site, fever, and fatigue, serious side effects are rare.

Vaccine procurement involves purchasing vaccines from manufacturers, with governments securing supplies through contracts and partnerships. Vaccine allocation ensures that vaccines are distributed to specific populations, with priority given to vulnerable groups like healthcare workers and the elderly. Vaccine prioritization determines which populations should receive vaccines first, based on risk factors. Vaccine passports are digital or physical documents that prove vaccination status, and may be required for travel or work, with regulations varying by jurisdiction. Vaccine mandates, which require vaccination for employment or participation in certain activities, remain a controversial issue. Vaccine regulations ensure vaccines are safe and effective, and policies governing vaccine use in schools, workplaces, and travel may change as supplies and public health conditions evolve.

Covid-19 Vaccination Market Driver

The expansion of vaccination programs is the key driver of the market. The market is experiencing significant growth due to the increasing demand for vaccines as governments and healthcare organizations prioritize widespread vaccination to control the virus and achieve herd immunity. This heightened demand leads to increased production and sales for vaccine manufacturers, resulting in long-term procurement contracts being signed to ensure a consistent vaccine supply. These contracts provide stability and revenue for manufacturers, with more contracts expected to be established as vaccination programs expand.

Vaccine distribution, administration, and logistics are crucial elements in the vaccine market, requiring efficient vaccine storage, transportation, and scheduling. Vaccine safety, efficacy, and monitoring are also vital considerations, along with addressing vaccine hesitancy and acceptance through education and outreach efforts. Vaccine regulations, policies, and campaigns are essential in ensuring vaccine coverage, immunity, and compliance with side effects and potential mandates or certificates.

Covid-19 Vaccination Market Trends

Rising research and development investment is the upcoming trend in the market. The Covid-19 pandemic has necessitated the rapid development, production, and distribution of vaccines to prevent and treat the disease caused by the SARS-CoV-2 virus. Governments and the private sector have collaborated to invest i

This dataset reports the daily reported number of the 7-day moving average rates of Deaths involving COVID-19 by vaccination status and by age group.

Learn how the Government of Ontario is helping to keep Ontarians safe during the 2019 Novel Coronavirus outbreak.

Effective November 14, 2024 this page will no longer be updated. Information about COVID-19 and other respiratory viruses is available on Public Health Ontario’s interactive respiratory virus tool: https://www.publichealthontario.ca/en/Data-and-Analysis/Infectious-Disease/Respiratory-Virus-Tool

Data includes:

• Date on which the death occurred
• Age group
• 7-day moving average of the last seven days of the death rate per 100,000 for those not fully vaccinated
• 7-day moving average of the last seven days of the death rate per 100,000 for those fully vaccinated
• 7-day moving average of the last seven days of the death rate per 100,000 for those vaccinated with at least one booster

Additional notes

As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm.

As of January 12, 2024, data from the date of January 1, 2024 onwards reflect updated population estimates. This update specifically impacts data for the 'not fully vaccinated' category.

On November 30, 2023 the count of COVID-19 deaths was updated to include missing historical deaths from January 15, 2020 to March 31, 2023.

CCM is a dynamic disease reporting system which allows ongoing update to data previously entered. As a result, data extracted from CCM represents a snapshot at the time of extraction and may differ from previous or subsequent results. Public Health Units continually clean up COVID-19 data, correcting for missing or overcounted cases and deaths. These corrections can result in data spikes and current totals being different from previously reported cases and deaths. Observed trends over time should be interpreted with caution for the most recent period due to reporting and/or data entry lags.

The data does not include vaccination data for people who did not provide consent for vaccination records to be entered into the provincial COVaxON system. This includes individual records as well as records from some Indigenous communities where those communities have not consented to including vaccination information in COVaxON.

“Not fully vaccinated” category includes people with no vaccine and one dose of double-dose vaccine. “People with one dose of double-dose vaccine” category has a small and constantly changing number. The combination will stabilize the results.

Spikes, negative numbers and other data anomalies: Due to ongoing data entry and data quality assurance activities in Case and Contact Management system (CCM) file, Public Health Units continually clean up COVID-19, correcting for missing or overcounted cases and deaths. These corrections can result in data spikes, negative numbers and current totals being different from previously reported case and death counts.

Public Health Units report cause of death in the CCM based on information available to them at the time of reporting and in accordance with definitions provided by Public Health Ontario. The medical certificate of death is the official record and the cause of death could be different.

Deaths are defined per the outcome field in CCM marked as “Fatal”. Deaths in COVID-19 cases identified as unrelated to COVID-19 are not included in the Deaths involving COVID-19 reported.

Rates for the most recent days are subject to reporting lags

All data reflects totals from 8 p.m. the previous day.

This dataset is subject to change.

Context

The data is collected from OWID (Our World in Data) GitHub repository, which is updated on daily bases.

Content

This dataset contains only one file vaccinations.csv, which contains the records of vaccination doses received by people from all the countries. * location: name of the country (or region within a country). * iso_code: ISO 3166-1 alpha-3 – three-letter country codes. * date: date of the observation. * total_vaccinations: total number of doses administered. This is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses). If a person receives one dose of the vaccine, this metric goes up by 1. If they receive a second dose, it goes up by 1 again. * total_vaccinations_per_hundred: total_vaccinations per 100 people in the total population of the country. * daily_vaccinations_raw: daily change in the total number of doses administered. It is only calculated for consecutive days. This is a raw measure provided for data checks and transparency, but we strongly recommend that any analysis on daily vaccination rates be conducted using daily_vaccinations instead. * daily_vaccinations: new doses administered per day (7-day smoothed). For countries that don't report data on a daily basis, we assume that doses changed equally on a daily basis over any periods in which no data was reported. This produces a complete series of daily figures, which is then averaged over a rolling 7-day window. An example of how we perform this calculation can be found here. * daily_vaccinations_per_million: daily_vaccinations per 1,000,000 people in the total population of the country. * people_vaccinated: total number of people who received at least one vaccine dose. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same. * people_vaccinated_per_hundred: people_vaccinated per 100 people in the total population of the country. * people_fully_vaccinated: total number of people who received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1. * people_fully_vaccinated_per_hundred: people_fully_vaccinated per 100 people in the total population of the country.

Note: for people_vaccinated and people_fully_vaccinated we are dependent on the necessary data being made available, so we may not be able to make these metrics available for some countries.

Acknowledgements

This data collected by Our World in Data which gets updated daily on their Github.

Inspiration

Possible uses for this dataset could include: - Sentiment analysis in a variety of forms - Statistical analysis over time.

As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

Context

To be honest it's pretty hard for you to find data on vaccine progress and especially time-based data on a country like Pakistan. So, I created this small but interactive notebook that will keep updating the database until everyone is vaccinated. In this project I have used Pandas for easy WebSracping to get the data from pharmaceutical-technology.com then I have created Sqlite3 database to store the data into three tables. It took me a few tries to get everything working smooth so I started using SQL queries to get the data and then used plotly to plot interactive visualization. I was not sure when they will update the website so, I have created few functions to avoid duplication of data and to inform me on telegram about updates. I have also uploaded the processed data to Kaggle from Deepnote which will be updated daily. At last, I have used the Deepnote Schedule notebook feature to run this notebook every day and successfully publishing the article You can find my work on Deepnote.

Content

• World_Vaccination_Progress.csv -> Countries Vaccination progress
• pakistan_time_series.csv -> Time series data of Pakistan vaccine progress
• world_time_series.csv -> Time series data of World vaccine progress

Columns: - Country :: Names of countries in the world - Doses Administered: Total Doses Administered - Doses per 1000 : Number of Doses per thousand - Fully Vaccinated Population (%) : Percentage of a fully vaccinated person in a country. - Vaccine being used in a country : Types of vaccines used in a country.

For Time-Series

• Date_Time : Timestamp of entry

Acknowledgements

I am thankful for Pharmaceutical Technology for updating the stats on daily basis and publicly provide real-time stats of world's vaccination drive. I also want to thank Deepnote for the introduction of the Schedule notebook feature that has made this automation possible.

Inspiration

The lack of data available in my country drove me to create an automated system that collects data from web. You can read more about it in my article. The second inspiration came from participating in Deepnote competition which was on the data Vaccination drive of your country or World.

The average for 2022 based on 187 countries was 84 percent. The highest value was in Antigua and Barbuda: 99 percent and the lowest value was in North Korea: 0 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

Vaccination rates among one-year-olds have risen drastically in the past four decades, with global coverage for some of the most important vaccines increasing from below twenty percent in 1980 to above eighty percent in 2021. Several vaccines introduced on a larger scale in the 1990s, such as the Hepatitis B vaccine, have increased from just one percent coverage to well over two thirds coverage today. As many infants receive multiple vaccines at one time, or as barriers to healthcare access are lifted, this has meant that global coverage trends have been fairly similar for the most common vaccines, and that coverage for newly developed vaccines has grown relatively quickly (such as the Hepatitis B and Inactivated Polio vaccines). Recent backsliding The COVID-19 pandemic marked the first time in recent history where coverage among one year olds dropped for multiple vaccines. In some cases, global coverage fell by as much as five or six percent for vaccines including diptheria/pertussus/tetanus, hepatitus B, measles, and polio. This backslide has been attributed to a variety of factors, such as weakened healthcare systems in less developed regions, the spread of misinformation surrounding vaccines, disruptions due to containment measures, supply chain issues, and the diversion of medical resources. It had been hoped that 2020 would be an anomaly, and that figures would return to their previous trajectory in 2021, but rising malnutrition and and weaker food supply to the poorest regions has exacerbated this further.

The following is data collected by Africa Data Hub covering vaccination data. It covers: Vaccine types | Africa/global vaccination rollouts | SARS-CoV-2 variants in Africa | Covax deliveries to Africa | Our World in Data - vaccinations | Media Hack Collective - vaccinations |

As well as Africa Maps as additional resources.

Example uses of this data: Africa vaccine tracker | Vaccine types and vaccination use | South African vaccinations widget | South African vaccination calculator | Daily confirmed cases in Africa

You may use this data in your own projects on the condition that you credit the appropriate sources. All data must be credited to Media Hack Collective and Africa Data Hub, with the exception of the Our World in Data - Vaccinations data which must be credited to Our World in Data.

Documentation for the datasets, including variables and methodology can be found here.

This statistic displays the percentage of the world population that has been vaccinated with select routine vaccinations as of 2022. According to the data, globally, just ** percent of people have had a last Rota vaccine against the Rotavirus. Rotavirus is responsible for an inflammation of the intestines and stomach and causes severe gastrointestinal and diarrheal disease. Vaccination success worldwide All around the world, vaccinations have been effective in reducing the number of cases and deaths of various communicable diseases since the introduction of global vaccination programs in the 1970’s. For example, between 2000 and 2021, millions of deaths due to measles have been averted all over the globe. The final aim of vaccination is to eradicate the disease entirely, as is the case with smallpox: no cases have been reported since 1978. Under-immunized groups Despite the success of immunization programs, there are still groups lacking the recommended vaccinations; this is often due to a lack of access or resources within a country or region, although under-immunization can also be a result of hesitancy due to personal beliefs. Individual rights involving compulsory vaccinations has also remained a hot topic over the years- for example, support for government-required childhood vaccinations has decreased in the U.S. since 1991. In order to further grow vaccination coverage, targeted strategies are needed for under-immunized and vaccine-hesitant groups using context-specific interventions to increase and monitor immunization rates.

Coronavirus Vaccine Market Outlook

The global market size for coronavirus vaccines was valued at around USD 45 billion in 2023, and it is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach approximately USD 79.8 billion by 2032. The primary growth factors driving this market include the ongoing need to manage COVID-19 outbreaks, the emergence of new virus variants, and the increasing global emphasis on pandemic preparedness and public health infrastructure enhancement.

One of the critical growth factors for the coronavirus vaccine market is the rising understanding of the long-term necessity for vaccination programs. Unlike initial assumptions that the pandemic could be quickly eradicated, it has become evident that COVID-19 may become endemic, requiring consistent and possibly seasonal vaccination efforts. This understanding has led both governments and private institutions to invest heavily in vaccine development, stockpiling, and distribution networks. Moreover, the introduction of booster doses to combat waning immunity has further solidified the market's growth trajectory.

Technological advancements in vaccine development have also played a significant role in the market's expansion. The rapid development and deployment of mRNA vaccines, such as those produced by Pfizer-BioNTech and Moderna, have set new benchmarks in the pharmaceutical industry. These innovations have not only increased the efficacy of vaccines but also reduced the time required for development and approval. This accelerated timeline is crucial for responding to new variants and potential future pandemics, driving further investments in cutting-edge vaccine technologies.

Regulatory support and international collaborations have also significantly influenced market growth. Governments worldwide have been proactive in approving emergency use authorizations and providing funding for vaccine research and development. Additionally, initiatives such as COVAX, led by the World Health Organization (WHO) and other global health organizations, aim to ensure equitable access to vaccines, particularly in low- and middle-income countries. These collaborative efforts are crucial for maintaining global health security and are anticipated to boost market demand.

From a regional perspective, North America and Europe have shown robust investments in vaccination programs and public health infrastructure, contributing to substantial market shares. However, the Asia Pacific region is expected to witness the highest growth rate, driven by large population bases, increasing healthcare spending, and concerted efforts to enhance vaccination coverage. Latin America and the Middle East & Africa are also emerging markets, with growing awareness and governmental initiatives to improve vaccine access and distribution.

Vaccine Type Analysis

The coronavirus vaccine market is segmented by vaccine type into mRNA vaccines, vector vaccines, protein subunit vaccines, inactivated vaccines, and others. Each of these types offers unique benefits and challenges, contributing to the overall diversity and resilience of the vaccine portfolio. mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna, have revolutionized the market with their high efficacy rates, rapid development cycles, and adaptability to new variants. These vaccines are set to dominate the market due to their technological superiority and strong clinical outcomes.

Vector vaccines, which use a modified virus to deliver genetic material into cells, represent another significant segment. Vaccines like the AstraZeneca-Oxford and Johnson & Johnson's Janssen fall into this category. These vaccines have shown efficacy in preventing severe disease and are easier to store and transport compared to mRNA vaccines. Their relatively lower production costs make them a viable option for mass immunization programs, especially in developing countries.

Protein subunit vaccines, which use harmless pieces of the virus to stimulate an immune response, are also gaining traction. Novavax is a key player in this segment, with its vaccine demonstrating strong efficacy and safety profiles. These vaccines are particularly appealing for individuals who may have allergic reactions to mRNA vaccines, offering an alternative that still provides robust protection. The scalability and stability of protein subunit vaccines make them an important component of the global vaccination strategy.

Inactivated vaccines, which use killed versions of the virus, have been

Content

Latest Covid-19 Vaccine Status of all the Countries in the World as on October 18, 2021

Attribute Information

Countries - Name of countries Doses administered per 100 people _ Number of vaccine doses administered per 100 people Total doses administered - Total number of doses administered % of population vaccinated - Percentage of population vaccinated % of population fully vaccinated- Percentage of population fully vaccinated

Source

Link : https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html

Thank You

As of July 4, 2022, Africa had administered around 41 doses of coronavirus (COVID-19) vaccines per 100 people. The vaccination rate in the continent was far slower than the world average, measured at 154 vaccines per 100 individuals on the same date. The vaccination in Africa has also been marked by a striking divide between countries. Africa started receiving vaccine supplies under the WHO-backed Covax facility in February 2021. Some African countries purchased additional doses, while others benefited from bilateral donations.